Pharma Anti-Counterfeiting 2010
The growth in counterfeit drugs and their level of sophistication is creating a growing headache for drug companies, health bodies and the consumer. Strategies to eliminate counterfeit drugs from the supply chain are becoming increasingly important to all stakeholders.
In this webinar series we consider some of the counterfeiting protection options available to pharma manufacturers and distributors, and ask what we can expect the long-term trends to be.
1. Integrating an anti-counterfeiting strategy into your business
Date: 2 Sep 2010
Time: TBC
Frequently the pharma industry, while recognising the importance of anti-counterfeit measures, views the solution as a bolt-on to the business, not an integral element of the business plan. In this session we address the implications of integrating methods across the business that contribute to overall anti-counterfeit strategy.
2. Securing the pharma supply chain
Date: 23 Sep 2010
Time: TBC
The need to appease stakeholder concern over supply chain integrity and the threat to brand image is clear. Changing compliance regimes and the increased inventory costs resulting from counterfeiting make action neccessary.
In this webinar you will learn:
- How ensuring compliance and real time end-to-end visibility can simultaneously optimise critical supply chain processes
- The regulatory and financial imperative
- Anti-counterfeiting as a platform for cost reduction
- How to deliver wider business benefits and drive ROI
MarketKey Updates
Upcoming Series
